Rhythm Biosciences Competitors

(BUX) (CNSX:BUX) and Rhythm Biosciences (ASX:RHY) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, analyst recommendations, valuation and risk.

Profitability

This table compares (BUX) and Rhythm Biosciences' net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current recommendations and price targets for (BUX) and Rhythm Biosciences, as reported by MarketBeat.

Earnings and Valuation

This table compares (BUX) and Rhythm Biosciences' revenue, earnings per share (EPS) and valuation.

(BUX) has higher earnings, but lower revenue than Rhythm Biosciences.

Summary

Rhythm Biosciences beats (BUX) on 1 of the 1 factors compared between the two stocks.

12144 (CNSX:IME) and Rhythm Biosciences (ASX:RHY) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk.

Valuation and Earnings

This table compares 12144 and Rhythm Biosciences' revenue, earnings per share (EPS) and valuation.

12144 has higher earnings, but lower revenue than Rhythm Biosciences.

Profitability

This table compares 12144 and Rhythm Biosciences' net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings and target prices for 12144 and Rhythm Biosciences, as reported by MarketBeat.com.

Summary

Rhythm Biosciences beats 12144 on 1 of the 1 factors compared between the two stocks.

BARD1 Life Sciences (ASX:BD1) and Rhythm Biosciences (ASX:RHY) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, profitability and risk.

Valuation and Earnings

This table compares BARD1 Life Sciences and Rhythm Biosciences' revenue, earnings per share and valuation.

Rhythm Biosciences has higher revenue and earnings than BARD1 Life Sciences.

Profitability

This table compares BARD1 Life Sciences and Rhythm Biosciences' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and price targets for BARD1 Life Sciences and Rhythm Biosciences, as provided by MarketBeat.

Summary

Rhythm Biosciences beats BARD1 Life Sciences on 3 of the 3 factors compared between the two stocks.

Rhythm Biosciences (ASX:RHY) and Charles River Laboratories International (CNSX:CRL) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Rhythm Biosciences and Charles River Laboratories International, as reported by MarketBeat.com.

Profitability

This table compares Rhythm Biosciences and Charles River Laboratories International's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Rhythm Biosciences and Charles River Laboratories International's revenue, earnings per share and valuation.

Charles River Laboratories International has lower revenue, but higher earnings than Rhythm Biosciences.

Summary

Rhythm Biosciences beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.

Cryosite (ASX:CTE) and Rhythm Biosciences (ASX:RHY) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, dividends, analyst recommendations, earnings and profitability.

Profitability

This table compares Cryosite and Rhythm Biosciences' net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Cryosite and Rhythm Biosciences, as reported by MarketBeat.com.

Valuation & Earnings

This table compares Cryosite and Rhythm Biosciences' gross revenue, earnings per share (EPS) and valuation.

Cryosite has higher revenue and earnings than Rhythm Biosciences.

Summary

Cryosite beats Rhythm Biosciences on 3 of the 3 factors compared between the two stocks.

Rhythm Biosciences (ASX:RHY) and dorsaVi (ASX:DVL) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk.

Profitability

This table compares Rhythm Biosciences and dorsaVi's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Rhythm Biosciences and dorsaVi, as reported by MarketBeat.com.

Valuation and Earnings

This table compares Rhythm Biosciences and dorsaVi's top-line revenue, earnings per share and valuation.

dorsaVi has higher revenue and earnings than Rhythm Biosciences.

Summary

dorsaVi beats Rhythm Biosciences on 3 of the 3 factors compared between the two stocks.